Methods of treating nerve entrapment syndromes

Details for Australian Patent Application No. 2003212473 (hide)

Owner ELAN PHARMACEUTICALS, INC.

Inventors O'Brien, Christopher

Agent Spruson & Ferguson

Pub. Number AU-A-2003212473

PCT Number PCT/US03/06233

PCT Pub. Number WO2003/073994

Priority 60/360,628 01.03.02 US

Filing date 27 February 2003

Wipo publication date 16 September 2003

Event Publications

24 July 2003 Complete Application Filed

  Priority application(s): 60/360,628 01.03.02 US

23 October 2003 Application Open to Public Inspection

  Published as AU-A-2003212473

31 July 2008 Assignment before Grant

  Elan Pharmaceuticals, Inc. The application has been assigned to Solstice Neurosciences, Inc.

28 May 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003212474-AUDIBLE FEEDBACK FROM POSITIONAL GUIDANCE SYSTEMS

2003212472-DELTA-SIGMA MODULATOR WITH FEED-FORWARD PATH